RJA
WGS icon

Raymond James & Associates’s GeneDx Holdings WGS Stock Holding History

Raymond James & Associates’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.09M Buy
+190,619
New +$6.44M ﹤0.01% 1346

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Raymond James & Associates's WGS Position: Q3 2024 in Review

Raymond James & Associates opened a new position in GeneDx Holdings (WGS) in Q3 2024: 190,619 shares worth $8.09M. The stake represents ﹤0.01% of the portfolio and ranks #1346 among its holdings.

136 funds tracked by Wall St. Rank hold WGS as of Q3 2024.

  • Raymond James & Associates held 190,619 shares of GeneDx Holdings worth $8.09M as of Q3 2024.
  • GeneDx Holdings was a new Raymond James & Associates position in Q3 2024.
  • GeneDx Holdings made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1346 holding.
  • 136 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.